Models of the Aging Brain Structure and Individual Decline
暂无分享,去创建一个
Christian Gaser | Gabriel Ziegler | Robert Dahnke | J. Whitwell | R. Dahnke | Gabriel Ziegler | Christian Gaser
[1] M. Jorge Cardoso,et al. [Accepted Manuscript] Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. , 2017 .
[2] W. M. van der Flier,et al. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline , 2017, Alzheimer's Research & Therapy.
[3] David T. Jones,et al. [18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease , 2018, Annals of neurology.
[4] Xin Xu,et al. Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer’s disease , 2017, Brain : a journal of neurology.
[5] J. Phillips,et al. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease , 2018, Human brain mapping.
[6] J. Trojanowski,et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers , 2016, Brain : a journal of neurology.
[7] Keith A. Johnson,et al. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals , 2017, The Journal of Neuroscience.
[8] Keith A. Johnson,et al. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex , 2017, JAMA neurology.
[9] Michael Schöll,et al. Amyloid and tau PET demonstrate region-specific associations in normal older people , 2017, NeuroImage.
[10] N. Tustison,et al. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake , 2018, Neurobiology of Aging.
[11] M. Jorge Cardoso,et al. Patterns of progressive atrophy vary with age in Alzheimer's disease patients , 2018, Neurobiology of Aging.
[12] J. Phillips,et al. 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease , 2017, The Journal of Nuclear Medicine.
[13] Yi Su,et al. Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia , 2017, Alzheimer disease and associated disorders.
[14] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[15] Keith A. Johnson,et al. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.
[16] G. Chételat,et al. Distinct influence of specific versus global connectivity on the different Alzheimer’s disease biomarkers , 2017, Brain : a journal of neurology.
[17] Christopher G Schwarz,et al. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. , 2018, Brain : a journal of neurology.
[18] M. Mintun,et al. Association between tau deposition and antecedent amyloid-&bgr; accumulation rates in normal and early symptomatic individuals , 2017, Brain : a journal of neurology.
[19] M. Mintun,et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition , 2017, Brain : a journal of neurology.
[20] Keith A. Johnson,et al. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease , 2018, JAMA neurology.
[21] R. Bateman,et al. Tau Positron Emission Tomography in Autosomal Dominant Alzheimer Disease: Small Windows, Big Picture. , 2018, JAMA neurology.
[22] Hanna Cho,et al. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease , 2017, Neurobiology of Aging.
[23] Gereon R Fink,et al. NETWORKS OF TAU DISTRIBUTION IN ALZHEIMER’S DISEASE , 2017, Alzheimer's & Dementia.
[24] Y. Noh,et al. Functional Connectivity of the Hippocampus in Early- and vs. Late-Onset Alzheimer's Disease , 2017, Journal of clinical neurology.
[25] O. Hansson,et al. Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks , 2017, Front. Neurosci..
[26] Shannon L. Risacher,et al. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline , 2017, Neurology.
[27] C. Jack,et al. Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study , 2017, The Lancet Neurology.
[28] M. Filippi,et al. Brain network connectivity differs in early-onset neurodegenerative dementia , 2017, Neurology.
[29] Luca Passamonti,et al. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy , 2018, Brain : a journal of neurology.
[30] Peter R. Martin,et al. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease. , 2018, Journal of Alzheimer's disease : JAD.
[31] Magda Tsolaki,et al. Heterogeneous patterns of brain atrophy in Alzheimer's disease , 2018, Neurobiology of Aging.
[32] Daniel R. Schonhaut,et al. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease , 2017, NeuroImage: Clinical.
[33] C. Jack,et al. Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study , 2017, The Lancet Neurology.
[34] Prashanthi Vemuri,et al. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample , 2017, Annals of neurology.
[35] P. Yushkevich,et al. Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex. , 2018, Journal of Alzheimer's disease : JAD.
[36] Gereon R. Fink,et al. Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.
[37] James B. Rowe,et al. PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers , 2017, Journal of Alzheimer's disease : JAD.
[38] Norbert Schuff,et al. Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns , 2017, Scientific Reports.
[39] Jorge Sepulcre,et al. Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline , 2017, Annals of neurology.
[40] Daniel C Alexander,et al. Data-driven models of dominantly-inherited Alzheimer’s disease progression , 2018, bioRxiv.
[41] David T. Jones,et al. Tau-negative amnestic dementia masquerading as Alzheimer disease dementia , 2018, Neurology.
[42] Rik Ossenkoppele,et al. Distinct 18F‐AV‐1451 tau PET retention patterns in early‐ and late‐onset Alzheimer's disease , 2017, Brain : a journal of neurology.
[43] Andrew J. Saykin,et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study , 2018, The Lancet Neurology.
[44] Christopher G Schwarz,et al. Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.
[45] Gereon R Fink,et al. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[46] Daniel R. Schonhaut,et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.
[47] M. Jorge Cardoso,et al. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy , 2017, Hippocampus.
[48] A. Brickman,et al. The effect of white matter hyperintensities on cognition is mediated by cortical atrophy , 2018, Neurobiology of Aging.
[49] Clifford R. Jack,et al. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum , 2017, Cortex.
[50] Clifford R. Jack,et al. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease , 2018, Alzheimer's & Dementia.